APO Research, Inc.

APO RESEARCH · REPORT

Std Self Diagnostics

Selected research

Market Analysis & Forecast

Global Std Self Diagnostics Market Analysis and Forecast 2026-2032

Market perspective

The global Std Self Diagnostics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Std Self Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Std Self Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Std Self Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Std Self Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Std Self Diagnostics include Orasure, Hologic Inc., F. Hoffmann-La Roche, DiaSorin, Danaher Corporation, Cepheid Inc., Bio-Rad Laboratories, BioMerieux and Becton Dickinson and Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Std Self Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Std Self Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Std Self Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Std Self Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Std Self Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Std Self Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Std Self Diagnostics Segment by Company

Orasure

Hologic Inc.

F. Hoffmann-La Roche

DiaSorin

Danaher Corporation

Cepheid Inc.

Bio-Rad Laboratories

BioMerieux

Becton Dickinson and Company

Alere Inc.

Affymetrix

Abbott Laboratories

Std Self Diagnostics Segment by Type

Testing Kit

Testing Device

Testing Strip/chip

Std Self Diagnostics Segment by Application

Diagnostic Centres

Hospitals

Homecare

Others

Std Self Diagnostics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Std Self Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Std Self Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Std Self Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Std Self Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Std Self Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Std Self Diagnostics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Std Self Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Testing Kit Major Player Table 3. Testing Device Major Player Table 4. Testing Strip/chip Major Player Table 5. Global Std Self Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Diagnostic Centres Major Player Table 7. Hospitals Major Player Table 8. Homecare Major Player Table 9. Others Major Player Table 10. Std Self Diagnostics Industry Trends Table 11. Std Self Diagnostics Industry Drivers Table 12. Std Self Diagnostics Industry Opportunities and Challenges Table 13. Std Self Diagnostics Industry Restraints Table 14. Global Std Self Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Std Self Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Std Self Diagnostics Market Share by Region (2021-2026) Table 17. Global Std Self Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Std Self Diagnostics Market Share by Region (2027-2032) Table 19. Global Std Self Diagnostics Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Std Self Diagnostics Revenue Market Share by Players (2021-2026) Table 21. Global Std Self Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Std Self Diagnostics Key Players Headquarters & Area Served Table 23. Global Std Self Diagnostics Players, Product Type & Application Table 24. Global Std Self Diagnostics Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Std Self Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Std Self Diagnostics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Std Self Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Std Self Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Std Self Diagnostics Revenue Market Share by Type (2021-2026) Table 31. Global Std Self Diagnostics Revenue Market Share by Type (2027-2032) Table 32. Global Std Self Diagnostics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Std Self Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Std Self Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Std Self Diagnostics Revenue Market Share by Application (2021-2026) Table 36. Global Std Self Diagnostics Revenue Market Share by Application (2027-2032) Table 37. Orasure Company Information Table 38. Orasure Business Overview Table 39. Orasure Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Orasure Std Self Diagnostics Product Portfolio Table 41. Orasure Recent Development Table 42. Hologic Inc. Company Information Table 43. Hologic Inc. Business Overview Table 44. Hologic Inc. Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Hologic Inc. Std Self Diagnostics Product Portfolio Table 46. Hologic Inc. Recent Development Table 47. F. Hoffmann-La Roche Company Information Table 48. F. Hoffmann-La Roche Business Overview Table 49. F. Hoffmann-La Roche Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. F. Hoffmann-La Roche Std Self Diagnostics Product Portfolio Table 51. F. Hoffmann-La Roche Recent Development Table 52. DiaSorin Company Information Table 53. DiaSorin Business Overview Table 54. DiaSorin Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. DiaSorin Std Self Diagnostics Product Portfolio Table 56. DiaSorin Recent Development Table 57. Danaher Corporation Company Information Table 58. Danaher Corporation Business Overview Table 59. Danaher Corporation Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Danaher Corporation Std Self Diagnostics Product Portfolio Table 61. Danaher Corporation Recent Development Table 62. Cepheid Inc. Company Information Table 63. Cepheid Inc. Business Overview Table 64. Cepheid Inc. Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Cepheid Inc. Std Self Diagnostics Product Portfolio Table 66. Cepheid Inc. Recent Development Table 67. Bio-Rad Laboratories Company Information Table 68. Bio-Rad Laboratories Business Overview Table 69. Bio-Rad Laboratories Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bio-Rad Laboratories Std Self Diagnostics Product Portfolio Table 71. Bio-Rad Laboratories Recent Development Table 72. BioMerieux Company Information Table 73. BioMerieux Business Overview Table 74. BioMerieux Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. BioMerieux Std Self Diagnostics Product Portfolio Table 76. BioMerieux Recent Development Table 77. Becton Dickinson and Company Company Information Table 78. Becton Dickinson and Company Business Overview Table 79. Becton Dickinson and Company Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Becton Dickinson and Company Std Self Diagnostics Product Portfolio Table 81. Becton Dickinson and Company Recent Development Table 82. Alere Inc. Company Information Table 83. Alere Inc. Business Overview Table 84. Alere Inc. Std Self Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Alere Inc. Std Self Diagnostics Product Portfolio Table 86. Alere Inc. Recent Development Table 87. Affymetrix Company Information Table 88. Affymetrix Business Overview Table 89. Affymetrix Std Self Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Affymetrix Std Self Diagnostics Product Portfolio Table 91. Affymetrix Recent Development Table 92. Abbott Laboratories Company Information Table 93. Abbott Laboratories Business Overview Table 94. Abbott Laboratories Std Self Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Abbott Laboratories Std Self Diagnostics Product Portfolio Table 96. Abbott Laboratories Recent Development Table 97. North America Std Self Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Std Self Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Std Self Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Std Self Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Std Self Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Std Self Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 103. North America Std Self Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 104. Europe Std Self Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Std Self Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Std Self Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Std Self Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Std Self Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Std Self Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 110. Europe Std Self Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 111. China Std Self Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 112. China Std Self Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 113. China Std Self Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 114. China Std Self Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Std Self Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 116. Asia Std Self Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 117. Asia Std Self Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 118. Asia Std Self Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Std Self Diagnostics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Std Self Diagnostics Revenue by Region (US$ Million) & (2021-2026) Table 121. Asia Std Self Diagnostics Revenue by Region (US$ Million) & (2027-2032) Table 122. SAMEA Std Self Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 123. SAMEA Std Self Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 124. SAMEA Std Self Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 125. SAMEA Std Self Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 126. SAMEA Std Self Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. SAMEA Std Self Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 128. SAMEA Std Self Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Std Self Diagnostics Image Figure 2. Global Std Self Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Std Self Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Testing Kit Image Figure 5. Testing Device Image Figure 6. Testing Strip/chip Image Figure 7. Global Std Self Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Std Self Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Diagnostic Centres Image Figure 10. Hospitals Image Figure 11. Homecare Image Figure 12. Others Image Figure 13. Global Std Self Diagnostics Market Size (US$ Million) & (2021-2032) Figure 14. Global Std Self Diagnostics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Std Self Diagnostics Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Std Self Diagnostics Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Std Self Diagnostics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Std Self Diagnostics Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Std Self Diagnostics Revenue Market Share by Type (2021-2032) Figure 21. Global Std Self Diagnostics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Std Self Diagnostics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Std Self Diagnostics Revenue Market Share by Application (2021-2032) Figure 24. North America Std Self Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Std Self Diagnostics Revenue Share by Type (2021-2032) Figure 26. North America Std Self Diagnostics Revenue Share by Application (2021-2032) Figure 27. North America Std Self Diagnostics Revenue Share by Country (2021-2032) Figure 28. United States Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Std Self Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Std Self Diagnostics Revenue Share by Type (2021-2032) Figure 33. Europe Std Self Diagnostics Revenue Share by Application (2021-2032) Figure 34. Europe Std Self Diagnostics Revenue Share by Country (2021-2032) Figure 35. Germany Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Std Self Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Std Self Diagnostics Revenue Share by Type (2021-2032) Figure 45. China Std Self Diagnostics Revenue Share by Application (2021-2032) Figure 46. Asia Std Self Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Std Self Diagnostics Revenue Share by Type (2021-2032) Figure 48. Asia Std Self Diagnostics Revenue Share by Application (2021-2032) Figure 49. Asia Std Self Diagnostics Revenue Share by Region (2021-2032) Figure 50. Japan Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Std Self Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Std Self Diagnostics Revenue Share by Type (2021-2032) Figure 58. SAMEA Std Self Diagnostics Revenue Share by Application (2021-2032) Figure 59. SAMEA Std Self Diagnostics Revenue Share by Country (2021-2032) Figure 60. Brazil Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Std Self Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Testing Kit
  • Testing Device
  • Testing Strip/chip
Applications
  • Diagnostic Centres
  • Hospitals
  • Homecare
  • Others
Companies covered
  • Orasure
  • Hologic Inc.
  • F. Hoffmann-La Roche
  • DiaSorin
  • Danaher Corporation
  • Cepheid Inc.
  • Bio-Rad Laboratories
  • BioMerieux
  • Becton Dickinson and Company
  • Alere Inc.
  • Affymetrix
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Std Self Diagnostics Market by Type
  3. 1.2.1 Global Std Self Diagnostics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Testing Kit
  5. 1.2.3 Testing Device
  6. 1.2.4 Testing Strip/chip
  7. 1.3 Std Self Diagnostics Market by Application
  8. 1.3.1 Global Std Self Diagnostics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Diagnostic Centres
  10. 1.3.3 Hospitals
  11. 1.3.4 Homecare
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Std Self Diagnostics Market Dynamics
  1. 2.1 Std Self Diagnostics Industry Trends
  2. 2.2 Std Self Diagnostics Industry Drivers
  3. 2.3 Std Self Diagnostics Industry Opportunities and Challenges
  4. 2.4 Std Self Diagnostics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Std Self Diagnostics Market Perspective (2021-2032)
  2. 3.2 Global Std Self Diagnostics Growth Trends by Region
  3. 3.2.1 Global Std Self Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Std Self Diagnostics Market Size by Region (2021-2026)
  5. 3.2.3 Global Std Self Diagnostics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Std Self Diagnostics Revenue by Players
  2. 4.1.1 Global Std Self Diagnostics Revenue by Players (2021-2026)
  3. 4.1.2 Global Std Self Diagnostics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Std Self Diagnostics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Std Self Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Std Self Diagnostics Key Players Headquarters & Area Served
  7. 4.4 Global Std Self Diagnostics Players, Product Type & Application
  8. 4.5 Global Std Self Diagnostics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Std Self Diagnostics Market CR5 and HHI
  11. 4.6.3 2025 Std Self Diagnostics Tier 1, Tier 2, and Tier 3
5 Std Self Diagnostics Market Size by Type
  1. 5.1 Global Std Self Diagnostics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Std Self Diagnostics Revenue by Type (2021-2032)
  3. 5.3 Global Std Self Diagnostics Revenue Market Share by Type (2021-2032)
6 Std Self Diagnostics Market Size by Application
  1. 6.1 Global Std Self Diagnostics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Std Self Diagnostics Revenue by Application (2021-2032)
  3. 6.3 Global Std Self Diagnostics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Orasure
  2. 7.1.1 Orasure Company Information
  3. 7.1.2 Orasure Business Overview
  4. 7.1.3 Orasure Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Orasure Std Self Diagnostics Product Portfolio
  6. 7.1.5 Orasure Recent Developments
  7. 7.2 Hologic Inc.
  8. 7.2.1 Hologic Inc. Company Information
  9. 7.2.2 Hologic Inc. Business Overview
  10. 7.2.3 Hologic Inc. Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hologic Inc. Std Self Diagnostics Product Portfolio
  12. 7.2.5 Hologic Inc. Recent Developments
  13. 7.3 F. Hoffmann-La Roche
  14. 7.3.1 F. Hoffmann-La Roche Company Information
  15. 7.3.2 F. Hoffmann-La Roche Business Overview
  16. 7.3.3 F. Hoffmann-La Roche Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 F. Hoffmann-La Roche Std Self Diagnostics Product Portfolio
  18. 7.3.5 F. Hoffmann-La Roche Recent Developments
  19. 7.4 DiaSorin
  20. 7.4.1 DiaSorin Company Information
  21. 7.4.2 DiaSorin Business Overview
  22. 7.4.3 DiaSorin Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DiaSorin Std Self Diagnostics Product Portfolio
  24. 7.4.5 DiaSorin Recent Developments
  25. 7.5 Danaher Corporation
  26. 7.5.1 Danaher Corporation Company Information
  27. 7.5.2 Danaher Corporation Business Overview
  28. 7.5.3 Danaher Corporation Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Danaher Corporation Std Self Diagnostics Product Portfolio
  30. 7.5.5 Danaher Corporation Recent Developments
  31. 7.6 Cepheid Inc.
  32. 7.6.1 Cepheid Inc. Company Information
  33. 7.6.2 Cepheid Inc. Business Overview
  34. 7.6.3 Cepheid Inc. Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cepheid Inc. Std Self Diagnostics Product Portfolio
  36. 7.6.5 Cepheid Inc. Recent Developments
  37. 7.7 Bio-Rad Laboratories
  38. 7.7.1 Bio-Rad Laboratories Company Information
  39. 7.7.2 Bio-Rad Laboratories Business Overview
  40. 7.7.3 Bio-Rad Laboratories Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Rad Laboratories Std Self Diagnostics Product Portfolio
  42. 7.7.5 Bio-Rad Laboratories Recent Developments
  43. 7.8 BioMerieux
  44. 7.8.1 BioMerieux Company Information
  45. 7.8.2 BioMerieux Business Overview
  46. 7.8.3 BioMerieux Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BioMerieux Std Self Diagnostics Product Portfolio
  48. 7.8.5 BioMerieux Recent Developments
  49. 7.9 Becton Dickinson and Company
  50. 7.9.1 Becton Dickinson and Company Company Information
  51. 7.9.2 Becton Dickinson and Company Business Overview
  52. 7.9.3 Becton Dickinson and Company Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Becton Dickinson and Company Std Self Diagnostics Product Portfolio
  54. 7.9.5 Becton Dickinson and Company Recent Developments
  55. 7.10 Alere Inc.
  56. 7.10.1 Alere Inc. Company Information
  57. 7.10.2 Alere Inc. Business Overview
  58. 7.10.3 Alere Inc. Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Alere Inc. Std Self Diagnostics Product Portfolio
  60. 7.10.5 Alere Inc. Recent Developments
  61. 7.11 Affymetrix
  62. 7.11.1 Affymetrix Company Information
  63. 7.11.2 Affymetrix Business Overview
  64. 7.11.3 Affymetrix Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Affymetrix Std Self Diagnostics Product Portfolio
  66. 7.11.5 Affymetrix Recent Developments
  67. 7.12 Abbott Laboratories
  68. 7.12.1 Abbott Laboratories Company Information
  69. 7.12.2 Abbott Laboratories Business Overview
  70. 7.12.3 Abbott Laboratories Std Self Diagnostics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Abbott Laboratories Std Self Diagnostics Product Portfolio
  72. 7.12.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Std Self Diagnostics Revenue (2021-2032)
  2. 8.2 North America Std Self Diagnostics Revenue by Type (2021-2032)
  3. 8.2.1 North America Std Self Diagnostics Revenue by Type (2021-2026)
  4. 8.2.2 North America Std Self Diagnostics Revenue by Type (2027-2032)
  5. 8.3 North America Std Self Diagnostics Revenue Share by Type (2021-2032)
  6. 8.4 North America Std Self Diagnostics Revenue by Application (2021-2032)
  7. 8.4.1 North America Std Self Diagnostics Revenue by Application (2021-2026)
  8. 8.4.2 North America Std Self Diagnostics Revenue by Application (2027-2032)
  9. 8.5 North America Std Self Diagnostics Revenue Share by Application (2021-2032)
  10. 8.6 North America Std Self Diagnostics Revenue by Country
  11. 8.6.1 North America Std Self Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Std Self Diagnostics Revenue by Country (2021-2026)
  13. 8.6.3 North America Std Self Diagnostics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Std Self Diagnostics Revenue (2021-2032)
  2. 9.2 Europe Std Self Diagnostics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Std Self Diagnostics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Std Self Diagnostics Revenue by Type (2027-2032)
  5. 9.3 Europe Std Self Diagnostics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Std Self Diagnostics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Std Self Diagnostics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Std Self Diagnostics Revenue by Application (2027-2032)
  9. 9.5 Europe Std Self Diagnostics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Std Self Diagnostics Revenue by Country
  11. 9.6.1 Europe Std Self Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Std Self Diagnostics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Std Self Diagnostics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Std Self Diagnostics Revenue (2021-2032)
  2. 10.2 China Std Self Diagnostics Revenue by Type (2021-2032)
  3. 10.2.1 China Std Self Diagnostics Revenue by Type (2021-2026)
  4. 10.2.2 China Std Self Diagnostics Revenue by Type (2027-2032)
  5. 10.3 China Std Self Diagnostics Revenue Share by Type (2021-2032)
  6. 10.4 China Std Self Diagnostics Revenue by Application (2021-2032)
  7. 10.4.1 China Std Self Diagnostics Revenue by Application (2021-2026)
  8. 10.4.2 China Std Self Diagnostics Revenue by Application (2027-2032)
  9. 10.5 China Std Self Diagnostics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Std Self Diagnostics Revenue (2021-2032)
  2. 11.2 Asia Std Self Diagnostics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Std Self Diagnostics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Std Self Diagnostics Revenue by Type (2027-2032)
  5. 11.3 Asia Std Self Diagnostics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Std Self Diagnostics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Std Self Diagnostics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Std Self Diagnostics Revenue by Application (2027-2032)
  9. 11.5 Asia Std Self Diagnostics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Std Self Diagnostics Revenue by Country
  11. 11.6.1 Asia Std Self Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Std Self Diagnostics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Std Self Diagnostics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Std Self Diagnostics Revenue (2021-2032)
  2. 12.2 SAMEA Std Self Diagnostics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Std Self Diagnostics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Std Self Diagnostics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Std Self Diagnostics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Std Self Diagnostics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Std Self Diagnostics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Std Self Diagnostics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Std Self Diagnostics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Std Self Diagnostics Revenue by Country
  11. 12.6.1 SAMEA Std Self Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Std Self Diagnostics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Std Self Diagnostics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.